Inhibitors of RAC1 and uses thereof for treating cancers
The present invention concerns a compound having the following formula (I): wherein: A is in particular —N(R′ a )—C(═O)—R, R′ a being H or a (C 1 -C 6 )alkyl group, and R being preferably a group having the following formula (II): X is in particular chosen from the group consisting of: —SO 2 —N(R′ b )—, R′ b being H or a (C 1 -C 6 )alkyl group, —N(R″ b )—SO 2 —, R″ b being H or a (C 1 -C 6 )alkyl group, —CO—NH—, and —NH—CO—, for use for the treatment of cancers, such as metastatic cancers.
1. A method for the treatment of cancer, comprising administering to a mammal in need thereof a therapeutically effective amount of a compound having the following formula (VII):
wherein:
p is an integer from 1 to 3 inclusive;
X′ is chosen from the group consisting of: —S—, —NH—, —NR d —, —CH 2 —, —SO 2 —, and —SO—, R d being H or a (C 1 -C 6 )alkyl group;
R 5 is a (C 1 -C 6 )alkyl group; and
the R 4 groups, identical or different, are chosen from the (C 1 -C 6 )alkyl groups.
2. The method of claim 1 , wherein X′ is —CH 2 —or —S—.
3. The method of claim 1 , wherein the compound of formula (VII) is the following compound:
4. (Allowed) The method of claim 1 , wherein the cancer is breast cancer.